These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2048 related items for PubMed ID: 15922813
21. Budesonide/formoterol maintenance and reliever therapy in Chinese patients with asthma. Lin JT, Chen P, Zhou X, Sun TY, Xie CM, Xiu QY, Yao WZ, Yang L, Yin KS, Zhang YM. Chin Med J (Engl); 2012 Sep; 125(17):2994-3001. PubMed ID: 22932169 [Abstract] [Full Text] [Related]
22. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study. Vogelmeier C, Naya I, Ekelund J. Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479 [Abstract] [Full Text] [Related]
27. [Evaluation of the clinical efficacy and the safety of salmeterol/fluticasone propionate accuhaler compared to budesonide turbuhalar in the control of adult asthma]. Zhong NS, Zheng JP, Cai BQ, Xie CM, Sun TY, Wang DQ, Lin YP, Chen BY, Tao JJ, Kang J, Li Q, Xu YP, Zhou X, Guo XJ, Chen XD, Yin KS, Zhang DP, Zhou JY, Shen HH, Qiu C, Feng YL, Xiao BR. Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr 01; 28(4):233-7. PubMed ID: 15854431 [Abstract] [Full Text] [Related]
28. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma. Ringdal N, Chuchalin A, Chovan L, Tudoric N, Maggi E, Whitehead PJ, EDICT Investigators. Respir Med; 2002 Nov 01; 96(11):851-61. PubMed ID: 12418582 [Abstract] [Full Text] [Related]
29. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. Hampel FC, Martin P, Mezzanotte WS. J Asthma; 2008 May 01; 45(4):265-72. PubMed ID: 18446589 [Abstract] [Full Text] [Related]
30. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L. Curr Med Res Opin; 2008 Mar 01; 24(3):879-94. PubMed ID: 18267051 [Abstract] [Full Text] [Related]
31. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma. Pearlman DS, LaForce CF, Kaiser K. Clin Ther; 2013 Jul 01; 35(7):950-66. PubMed ID: 23870606 [Abstract] [Full Text] [Related]
35. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Kuna P, Creemers JP, Vondra V, Black PN, Lindqvist A, Nihlen U, Vogelmeier C. Respir Med; 2006 Dec 01; 100(12):2151-9. PubMed ID: 16701989 [Abstract] [Full Text] [Related]
36. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma. Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K. Pulm Pharmacol Ther; 2014 Feb 01; 27(1):52-6. PubMed ID: 23583566 [Abstract] [Full Text] [Related]
37. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma]. Korn S, Vogelmeier C, Buhl R. Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216 [Abstract] [Full Text] [Related]
38. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Ann Allergy Asthma Immunol; 1999 Mar 15; 82(3):257-65. PubMed ID: 10094216 [Abstract] [Full Text] [Related]
40. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Jenkins C, Kolarikova R, Kuna P, Caillaud D, Sanchis J, Popp W, Pettersson E. Respirology; 2006 May 15; 11(3):276-86. PubMed ID: 16635085 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]